Early findings from a phase 3 clinical trial report promising results
The interim results from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for…
The interim results from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for…